Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate

Janet A. Stockheim; Jorge J. Daaboul; Ram Yogev; Susan P. Scully; Helen Binns; Ellen Chadwick

doi:10.1016/S0022-3476(99)70467-1

Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate

Janet A. Stockheim^*, Jorge J. Daaboul, Ram Yogev, Susan P. Scully, Helen Binns, Ellen Chadwick

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Abstract

Symptoms and laboratory evidence of adrenal suppression developed in 2 children with the human immunodeficiency virus after megestrol acetate (MA) therapy was discontinued; both required transient glucocorticoid replacement therapy. High-dose corticotropin stimulation testing performed on children with the human immunodeficiency virus treated or not treated with MA showed that baseline and post-corticotropin cortisol levels were extremely low in 7 of 10 treated patients and normal in 10 of 10 members of a control group (P < .01). MA may suppress adrenal function, and replacement glucocorticoids may prevent or relieve associated symptoms at times of severe stress or on discontinuation of MA therapy.

Original language	English (US)
Pages (from-to)	368-370
Number of pages	3
Journal	journal of pediatrics
Volume	134
Issue number	3
DOIs	https://doi.org/10.1016/S0022-3476(99)70467-1
State	Published - 1999

Funding

Drs Stockheim and Chadwick received financial support from Bristol-Myers Squibb, the maker of Megace, to present this research in abstract form at the Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, February 1-5, 1998.

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0022-3476(99)70467-1

Cite this

@article{768aece7c0674e768decd851d31b8e1c,

title = "Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate",

abstract = "Symptoms and laboratory evidence of adrenal suppression developed in 2 children with the human immunodeficiency virus after megestrol acetate (MA) therapy was discontinued; both required transient glucocorticoid replacement therapy. High-dose corticotropin stimulation testing performed on children with the human immunodeficiency virus treated or not treated with MA showed that baseline and post-corticotropin cortisol levels were extremely low in 7 of 10 treated patients and normal in 10 of 10 members of a control group (P < .01). MA may suppress adrenal function, and replacement glucocorticoids may prevent or relieve associated symptoms at times of severe stress or on discontinuation of MA therapy.",

author = "Stockheim, {Janet A.} and Daaboul, {Jorge J.} and Ram Yogev and Scully, {Susan P.} and Helen Binns and Ellen Chadwick",

note = "Funding Information: Drs Stockheim and Chadwick received financial support from Bristol-Myers Squibb, the maker of Megace, to present this research in abstract form at the Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, February 1-5, 1998. ",

year = "1999",

doi = "10.1016/S0022-3476(99)70467-1",

language = "English (US)",

volume = "134",

pages = "368--370",

journal = "journal of pediatrics",

issn = "0022-3476",

publisher = "Mosby Inc.",

number = "3",

}

TY - JOUR

T1 - Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate

AU - Stockheim, Janet A.

AU - Daaboul, Jorge J.

AU - Yogev, Ram

AU - Scully, Susan P.

AU - Binns, Helen

AU - Chadwick, Ellen

N1 - Funding Information: Drs Stockheim and Chadwick received financial support from Bristol-Myers Squibb, the maker of Megace, to present this research in abstract form at the Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, February 1-5, 1998.

PY - 1999

Y1 - 1999

N2 - Symptoms and laboratory evidence of adrenal suppression developed in 2 children with the human immunodeficiency virus after megestrol acetate (MA) therapy was discontinued; both required transient glucocorticoid replacement therapy. High-dose corticotropin stimulation testing performed on children with the human immunodeficiency virus treated or not treated with MA showed that baseline and post-corticotropin cortisol levels were extremely low in 7 of 10 treated patients and normal in 10 of 10 members of a control group (P < .01). MA may suppress adrenal function, and replacement glucocorticoids may prevent or relieve associated symptoms at times of severe stress or on discontinuation of MA therapy.

AB - Symptoms and laboratory evidence of adrenal suppression developed in 2 children with the human immunodeficiency virus after megestrol acetate (MA) therapy was discontinued; both required transient glucocorticoid replacement therapy. High-dose corticotropin stimulation testing performed on children with the human immunodeficiency virus treated or not treated with MA showed that baseline and post-corticotropin cortisol levels were extremely low in 7 of 10 treated patients and normal in 10 of 10 members of a control group (P < .01). MA may suppress adrenal function, and replacement glucocorticoids may prevent or relieve associated symptoms at times of severe stress or on discontinuation of MA therapy.

UR - http://www.scopus.com/inward/record.url?scp=0033499793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033499793&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(99)70467-1

DO - 10.1016/S0022-3476(99)70467-1

M3 - Article

C2 - 10064680

AN - SCOPUS:0033499793

SN - 0022-3476

VL - 134

SP - 368

EP - 370

JO - journal of pediatrics

JF - journal of pediatrics

IS - 3

ER -

Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate

Abstract

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this